Skip to main content

Advertisement

Table 1 Patient characteristics in different cohorts

From: Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity

Characteristics Prone volumetric modulated arc therapy group (n = 12) Supine box group (n = 6)
Age (years)   
   Median 52.5 57.5
   Range 38 to 72 53 to 71
Sex   
   Male 7 5
   Female 5 1
Clinical tumor stage   
   T2 1 0
   T3 8 5
   T4 3 1
Clinical node stage   
   N0 2 2
   N1 2 4
   N2 8 0
Clinical stage   
   IIA 2 2
   IIIB 6 2
   IIIC 4 0
   IVA 0 2
Distance from the anal verge   
   < 5 cm 5 1
   5 to 10 cm 7 4
   ≥ 10 cm 0 1
Chemotherapy   
   Bevacizumab + FOLFOX (leucovorin, fluorouracil, and oxaliplatin) 11 6
   Bevacizumab +5-fluorouracil 1 0
Surgical type   
   Lower anterior resection 9 3
   Abdominoperineal resection 3 1